{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T03:19:59Z","timestamp":1791429599774,"version":"4.3.3"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T00:00:00Z","timestamp":1757376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T00:00:00Z","timestamp":1757376000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Forschungszentrum Borstel - Leibniz Lungenzentrum"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Volatile anesthetics are gaining recognition for their benefits in long-term sedation of mechanically ventilated patients with bacterial pneumonia and acute respiratory distress syndrome. In addition to their sedative role, they also exhibit anti-bacterial and anti-inflammatory properties, though the mechanisms behind these effects remain only partially understood. In vitro studies examining the prolonged impact of volatile anesthetics on bacterial growth, inflammatory cytokine response, and surfactant proteins \u2014 key to maintaining lung homeostasis \u2014 are still lacking.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Using an anaerobic chamber setup, we evaluated the effects of the most commonly used volatile anesthetics, Sevoflurane and Desflurane, at clinically relevant concentrations on the growth of <jats:italic>Pseudomonas aeruginosa<\/jats:italic>, <jats:italic>Escherichia coli<\/jats:italic>, and <jats:italic>Staphylococcus aureus<\/jats:italic>. Bacterial growth was monitored over 24\u00a0h, assessing OD<jats:sub>600<\/jats:sub>, CFU\/ml, and growth rate during the <jats:italic>log <\/jats:italic>\n              <jats:italic>phase<\/jats:italic>. In the same setup, but with aerobic conditions, we investigated the immunomodulatory properties of both anesthetics on human A549 cells, either with or without bacterial lipopolysaccharide (LPS, 1\u00a0\u00b5g\/ml) stimulation. Over 48\u00a0h, we analyzed pro-inflammatory chemokine release using ELISA and assessed surfactant protein expression with Western blot analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Sevoflurane and Desflurane significantly reduced <jats:italic>Pseudomonas aeruginosa<\/jats:italic> growth as expressed consistently in OD<jats:sub>600<\/jats:sub> and CFU\/ml starting after 12\u00a0h. Both volatile anesthetics also significantly reduced <jats:italic>Staphylococcus aureus<\/jats:italic> OD<jats:sub>600<\/jats:sub> starting after 21\u00a0h. Sevoflurane (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01) and Desflurane (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) counteracted LPS-induced interleukin-8 release by A549 cells after 48\u00a0h and significantly ( <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01 and <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05) enhanced the expression of the propeptide of surfactant protein C after 24\u00a0h.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Prolonged anti-bacterial and anti-inflammatory effects of Sevoflurane and Desflurane include both the reduction of <jats:italic>Pseudomonas aeruginosa<\/jats:italic> and <jats:italic>Staphylococcus aureus<\/jats:italic> growth as well as the inhibition of LPS-induced chemokine release by A549 epithelial cells paralleled by an increase of surfactant protein expression. These effects highlight the potential of volatile anesthetics beyond sedation in supporting lung function in ventilated patients with respiratory failure.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12890-025-03849-w","type":"journal-article","created":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T13:27:40Z","timestamp":1757424460000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Prolonged in vitro anti-bacterial, anti-inflammatory, and surfactant-promoting effects of volatile anesthetics"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9412-843X","authenticated-orcid":false,"given":"Claudia","family":"Scheffz\u00fck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"L\u00fchrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Brinkmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominika","family":"Biedziak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Gloystein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Kellner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cordula","family":"Stamme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,9]]},"reference":[{"issue":"3","key":"3849_CR1","doi-asserted-by":"publisher","first-page":"e15958","DOI":"10.5812\/traumamon.15958","volume":"19","author":"R Ghanbarpour","year":"2014","unstructured":"Ghanbarpour R, Saghafinia M, Ramezani Binabaj M, Madani SJ, Tadressi D, Forozanmehr MJ. Pulmonary infections in ICU patients without underlying disease on ventilators. Trauma Mon. 2014;19(3):e15958.","journal-title":"Trauma Mon"},{"issue":"4","key":"3849_CR2","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1055\/s-0032-1321985","volume":"33","author":"CE Cox","year":"2012","unstructured":"Cox CE, Carson SS. Medical and economic implications of prolonged mechanical ventilation and expedited post-acute care. Semin Respir Crit Care Med. 2012;33(4):357\u201361.","journal-title":"Semin Respir Crit Care Med"},{"key":"3849_CR3","unstructured":"European Centre for Disease Prevention and Control. Annual Epidemiological Report for 2018\u2013 Healthcare- associated infections acquired in intensive care units. ECDC [Internet]. 2023;Annual epidemiological report for 2018. Available from: https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/healthcare-associated-infections-intensive-care-units-annual-epidemiological-report-2018_0.pdf. Accessed 3 Oct 2024."},{"issue":"5","key":"3849_CR4","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1007\/s00134-020-05980-0","volume":"46","author":"L Papazian","year":"2020","unstructured":"Papazian L, Klompas M, Luyt CE. Ventilator-associated pneumonia in adults: a narrative review. Intensive Care Med. 2020;46(5):888\u2013906.","journal-title":"Intensive Care Med"},{"issue":"1","key":"3849_CR5","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13613-019-0517-8","volume":"9","author":"J Heider","year":"2019","unstructured":"Heider J, Bansbach J, Kaufmann K, Heinrich S, Loop T, Kalbhenn J. Does volatile sedation with Sevoflurane allow spontaneous breathing during prolonged prone positioning in intubated ARDS patients? A retrospective observational feasibility trial. Ann Intensive Care. 2019;9(1):41.","journal-title":"Ann Intensive Care"},{"issue":"1","key":"3849_CR6","doi-asserted-by":"publisher","first-page":"e0170089","DOI":"10.1371\/journal.pone.0170089","volume":"12","author":"M Chamberlain","year":"2017","unstructured":"Chamberlain M, Koutsogiannaki S, Schaefers M, Babazada H, Liu R, Yuki K. The differential effects of anesthetics on bacterial behaviors. PLoS ONE. 2017;12(1):e0170089.","journal-title":"PLoS ONE"},{"issue":"2","key":"3849_CR7","first-page":"84","volume":"30","author":"M Mart\u00ednez-Serrano","year":"2017","unstructured":"Mart\u00ednez-Serrano M, Ger\u00f3nimo-Pardo M, Mart\u00ednez-Monsalve A, Crespo-S\u00e1nchez MD. Antibacterial effect of Sevoflurane and isoflurane. Rev Esp Quimioter Publicacion Soc Esp Quimioter. 2017;30(2):84\u20139.","journal-title":"Rev Esp Quimioter Publicacion Soc Esp Quimioter"},{"issue":"3","key":"3849_CR8","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1007\/s00540-007-0520-3","volume":"21","author":"L Karabiyik","year":"2007","unstructured":"Karabiyik L, T\u00fcrkan H, Ozi\u015fik T, Sara\u00e7li MA, Haznedaro\u011flu T. Effects of Sevoflurane and\/or nitrous oxide on bacterial growth in in vitro culture conditions. J Anesth. 2007;21(3):436\u20138.","journal-title":"J Anesth"},{"issue":"1","key":"3849_CR9","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0022-1759(96)00236-0","volume":"202","author":"RJ Szarka","year":"1997","unstructured":"Szarka RJ, Wang N, Gordon L, Nation PN, Smith RH. A murine model of pulmonary damage induced by lipopolysaccharide via intranasal instillation. J Immunol Methods. 1997;202(1):49\u201357.","journal-title":"J Immunol Methods"},{"issue":"4","key":"3849_CR10","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3109\/01902149709039228","volume":"23","author":"HP van Helden","year":"1997","unstructured":"van Helden HP, Kuijpers WC, Steenvoorden D, Go C, Bruijnzeel PL, van Eijk M, et al. Intratracheal aerosolization of endotoxin (LPS) in the rat: a comprehensive animal model to study adult (acute) respiratory distress syndrome. Exp Lung Res. 1997;23(4):297\u2013316.","journal-title":"Exp Lung Res"},{"issue":"4","key":"3849_CR11","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1080\/1061186X.2019.1678169","volume":"28","author":"D Li","year":"2020","unstructured":"Li D, Qi C, Zhou J, Wen Z, Zhu X, Xia H, et al. LPS-induced inflammation delays the transportation of ASP\u2009+\u2009due to down-regulation of OCTN1\/2 in alveolar epithelial cells. J Drug Target. 2020;28(4):437\u201347.","journal-title":"J Drug Target"},{"issue":"4","key":"3849_CR12","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3892\/etm.2022.11174","volume":"23","author":"X Yang","year":"2022","unstructured":"Yang X, Ma L. Post-treatment with Propofol inhibits inflammatory response in LPS-induced alveolar type II epithelial cells. Exp Ther Med. 2022;23(4):249.","journal-title":"Exp Ther Med"},{"issue":"1","key":"3849_CR13","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1183\/09031936.00046307","volume":"31","author":"T Yue","year":"2008","unstructured":"Yue T, Roth Z\u2019graggen, Blumenthal B, Neff S, Reyes SB, Booy L. Postconditioning with a volatile anaesthetic in alveolar epithelial cells in vitro. Eur Respir J. 2008;31(1):118\u201325.","journal-title":"Eur Respir J"},{"issue":"6","key":"3849_CR14","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1097\/ALN.0b013e3181bdf857","volume":"111","author":"S Voigtsberger","year":"2009","unstructured":"Voigtsberger S, Lachmann RA, Leutert AC, Schl\u00e4pfer M, Booy C, Reyes L, et al. Sevoflurane ameliorates gas exchange and attenuates lung damage in experimental lipopolysaccharide-induced lung injury. Anesthesiology. 2009;111(6):1238\u201348.","journal-title":"Anesthesiology"},{"issue":"2","key":"3849_CR15","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1097\/ALN.0000000000001195","volume":"125","author":"LM Stollings","year":"2016","unstructured":"Stollings LM, Jia LJ, Tang P, Dou H, Lu B, Xu Y. Immune modulation by volatile anesthetics. Anesthesiology. 2016;125(2):399\u2013411.","journal-title":"Anesthesiology"},{"issue":"3","key":"3849_CR16","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1165\/rcmb.2010-0451OC","volume":"45","author":"M Urner","year":"2011","unstructured":"Urner M, Limbach LK, Herrmann IK, M\u00fcller-Edenborn B, Roth-Z\u2019Graggen B, Schlicker A, et al. Fluorinated groups mediate the Immunomodulatory effects of volatile anesthetics in acute cell injury. Am J Respir Cell Mol Biol. 2011;45(3):617\u201324.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1","key":"3849_CR17","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1213\/ANE.0000000000001530","volume":"124","author":"P Kellner","year":"2017","unstructured":"Kellner P, M\u00fcller M, Piegeler T, Eugster P, Booy C, Schl\u00e4pfer M, et al. Sevoflurane abolishes oxygenation impairment in a long-term rat model of acute lung injury. Anesth Analg. 2017;124(1):194\u2013203.","journal-title":"Anesth Analg"},{"issue":"2","key":"3849_CR18","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1213\/ANE.0000000000001927","volume":"125","author":"MN Ara\u00fajo","year":"2017","unstructured":"Ara\u00fajo MN, Santos CL, Samary CS, Heil LBB, Cavalcanti VCM, Cruz FF, et al. Sevoflurane, compared with isoflurane, minimizes lung damage in pulmonary but not in extrapulmonary acute respiratory distress syndrome in rats. Anesth Analg. 2017;125(2):491\u20138.","journal-title":"Anesth Analg"},{"issue":"6","key":"3849_CR19","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1164\/rccm.201604-0686OC","volume":"195","author":"M Jabaudon","year":"2017","unstructured":"Jabaudon M, Boucher P, Imhoff E, Chabanne R, Faure JS, Roszyk L, et al. Sevoflurane for sedation in acute respiratory distress syndrome. A randomized controlled pilot study. Am J Respir Crit Care Med. 2017;195(6):792\u2013800.","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"3849_CR20","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1164\/rccm.201709-1864LE","volume":"197","author":"A Rich\u00e9","year":"2018","unstructured":"Rich\u00e9 A, Adam N, Monsel A, Xia J, Langeron O, Rouby JJ. Sevoflurane in acute respiratory distress syndrome: are lung protection and anesthesia depth influenced by pulmonary morphology?? Am J Respir Crit Care Med. 2018;197(6):830\u20132.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"3849_CR21","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.chemphyslip.2006.02.017","volume":"141","author":"AG Serrano","year":"2006","unstructured":"Serrano AG, P\u00e9rez-Gil J. Protein\u2013lipid interactions and surface activity in the pulmonary surfactant system. Chem Phys Lipids. 2006;141(1):105\u201318.","journal-title":"Chem Phys Lipids"},{"issue":"1","key":"3849_CR22","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.micinf.2011.08.019","volume":"14","author":"JR Glasser","year":"2012","unstructured":"Glasser JR, Mallampalli RK. Surfactant and its role in the pathobiology of pulmonary infection. Microbes Infect. 2012;14(1):17\u201325.","journal-title":"Microbes Infect"},{"issue":"5","key":"3849_CR23","doi-asserted-by":"publisher","first-page":"L882","DOI":"10.1152\/ajplung.00418.2017","volume":"314","author":"H Jin","year":"2018","unstructured":"Jin H, Ciechanowicz AK, Kaplan AR, Wang L, Zhang PX, Lu YC, et al. Surfactant protein C dampens inflammation by decreasing JAK\/STAT activation during lung repair. Am J Physiol - Lung Cell Mol Physiol. 2018;314(5):L882\u201392.","journal-title":"Am J Physiol - Lung Cell Mol Physiol"},{"issue":"D1","key":"3849_CR24","doi-asserted-by":"publisher","first-page":"D631","DOI":"10.1093\/nar\/gky879","volume":"47","author":"LC Reimer","year":"2019","unstructured":"Reimer LC, Vetcininova A, Carbasse JS, S\u00f6hngen C, Gleim D, Ebeling C, et al. BacDive in 2019: bacterial phenotypic data for High-throughput biodiversity analysis. Nucleic Acids Res. 2019;47(D1):D631\u20136.","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"3849_CR25","first-page":"572","volume":"13","author":"BW Holloway","year":"1955","unstructured":"Holloway BW. Genetic recombination in Pseudomonas aeruginosa. J Gen Microbiol. 1955;13(3):572\u201381.","journal-title":"J Gen Microbiol"},{"issue":"5","key":"3849_CR26","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1093\/jnci\/51.5.1417","volume":"51","author":"DJ Giard","year":"1973","unstructured":"Giard DJ, Aaronson SA, Todaro GJ, Arnstein P, Kersey JH, Dosik H, et al. In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J Natl Cancer Inst. 1973;51(5):1417\u201323.","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"3849_CR27","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/ijc.2910170110","volume":"17","author":"M Lieber","year":"1976","unstructured":"Lieber M, Todaro G, Smith B, Szakal A, Nelson-Rees W. A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells. Int J Cancer. 1976;17(1):62\u201370.","journal-title":"Int J Cancer"},{"issue":"4","key":"3849_CR28","doi-asserted-by":"publisher","first-page":"L684","DOI":"10.1152\/ajplung.00320.2000","volume":"282","author":"DV Pechkovsky","year":"2002","unstructured":"Pechkovsky DV, Zissel G, Goldmann T, Einhaus M, Taube C, Magnussen H, et al. Pattern of NOS2 and NOS3 mRNA expression in human A549 cells and primary cultured AEC II. Am J Physiol Lung Cell Mol Physiol. 2002;282(4):L684\u201392.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"11","key":"3849_CR29","first-page":"1","volume":"4","author":"F Widdel","year":"2007","unstructured":"Widdel F. Theory and measurement of bacterial growth. Dalam Grundpraktikum Mikrobiol. 2007;4(11):1\u201311.","journal-title":"Dalam Grundpraktikum Mikrobiol"},{"key":"3849_CR30","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1016\/j.mex.2019.09.036","volume":"6","author":"JL Wood","year":"2019","unstructured":"Wood JL, Osman A, Wade SA. An efficient, cost-effective method for determining the growth rate of sulfate-reducing bacteria using spectrophotometry. MethodsX. 2019;6:2248\u201357.","journal-title":"MethodsX"},{"issue":"5","key":"3849_CR31","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1111\/j.1742-4658.2006.05124.x","volume":"273","author":"J Li","year":"2006","unstructured":"Li J, Liepinsh E, Almlen A, Thyberg J, Curstedt T, Jornvall H, et al. Structure and influence on stability and activity of the N-terminal propeptide part of lung surfactant protein C. FEBS J. 2006;273(5):926\u201335.","journal-title":"FEBS J"},{"issue":"11","key":"3849_CR32","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/S2213-2600(21)00323-4","volume":"9","author":"A Meiser","year":"2021","unstructured":"Meiser A, Volk T, Wallenborn J, Guenther U, Becher T, Bracht H, et al. Inhaled isoflurane via the anaesthetic conserving device versus Propofol for sedation of invasively ventilated patients in intensive care units in Germany and slovenia: an open-label, phase 3, randomised controlled, non-inferiority trial. Lancet Respir Med. 2021;9(11):1231\u201340.","journal-title":"Lancet Respir Med"},{"issue":"23","key":"3849_CR33","doi-asserted-by":"publisher","first-page":"12808","DOI":"10.3390\/ijms252312808","volume":"25","author":"K Markowska","year":"2024","unstructured":"Markowska K, Szymanek-Majchrzak K, Pituch H, Majewska A. Understanding Quorum-Sensing and biofilm forming in anaerobic bacterial communities. Int J Mol Sci. 2024;25(23):12808.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3849_CR34","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3934\/microbiol.2018.1.140","volume":"4","author":"T Trunk","year":"2018","unstructured":"Trunk T, Khalil HS, Leo JC. Bacterial autoaggregation. AIMS Microbiol. 2018;4(1):140\u201364.","journal-title":"AIMS Microbiol"},{"issue":"1","key":"3849_CR35","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1089\/mdr.2018.0027","volume":"25","author":"V Cepas","year":"2019","unstructured":"Cepas V, L\u00f3pez Y, Mu\u00f1oz E, Rolo D, Ardanuy C, Mart\u00ed S, et al. Relationship between biofilm formation and antimicrobial resistance in Gram-Negative Bacteria. Microb Drug Resist Larchmt N. 2019;25(1):72\u20139.","journal-title":"Microb Drug Resist Larchmt N"},{"issue":"5","key":"3849_CR36","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1177\/1753425909341807","volume":"16","author":"CD Ciornei","year":"2010","unstructured":"Ciornei CD, Novikov A, Beloin C, Fitting C, Caroff M, Ghigo JM, et al. Biofilm-forming Pseudomonas aeruginosa bacteria undergo lipopolysaccharide structural modifications and induce enhanced inflammatory cytokine response in human monocytes. Innate Immun. 2010;16(5):288\u2013301.","journal-title":"Innate Immun"},{"key":"3849_CR37","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3389\/fcimb.2014.00178","volume":"4","author":"JL Lister","year":"2014","unstructured":"Lister JL, Horswill AR. Staphylococcus aureus biofilms: recent developments in biofilm dispersal. Front Cell Infect Microbiol. 2014;4:178.","journal-title":"Front Cell Infect Microbiol"},{"issue":"4","key":"3849_CR38","doi-asserted-by":"publisher","first-page":"603","DOI":"10.2217\/fmb.10.16","volume":"5","author":"M Schobert","year":"2010","unstructured":"Schobert M, Tielen P. Contribution of oxygen-limiting conditions to persistent infection of Pseudomonas aeruginosa. Future Microbiol. 2010;5(4):603\u201321.","journal-title":"Future Microbiol"},{"issue":"12","key":"3849_CR39","doi-asserted-by":"publisher","first-page":"e1005341","DOI":"10.1371\/journal.ppat.1005341","volume":"11","author":"AD Wilde","year":"2015","unstructured":"Wilde AD, Snyder DJ, Putnam NE, Valentino MD, Hammer ND, Lonergan ZR, et al. Bacterial hypoxic responses revealed as critical determinants of the Host-Pathogen outcome by TnSeq analysis of Staphylococcus aureus invasive infection. PLOS Pathog. 2015;11(12):e1005341.","journal-title":"PLOS Pathog"},{"issue":"2","key":"3849_CR40","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3390\/biom8020029","volume":"8","author":"EF Haney","year":"2018","unstructured":"Haney EF, Trimble MJ, Cheng JT, Vall\u00e9 Q, Hancock REW. Critical assessment of methods to quantify biofilm growth and evaluate antibiofilm activity of host defence peptides. Biomolecules. 2018;8(2):29.","journal-title":"Biomolecules"},{"issue":"2","key":"3849_CR41","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/path.1491","volume":"202","author":"M Bhatia","year":"2004","unstructured":"Bhatia M, Moochhala S. Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. J Pathol. 2004;202(2):145\u201356.","journal-title":"J Pathol"},{"issue":"6","key":"3849_CR42","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/1043-4666(92)90025-M","volume":"4","author":"PG Jorens","year":"1992","unstructured":"Jorens PG, Van Damme J, De Backer W, Bossaert L, De Jongh RF, Herman AG, et al. Interleukin 8 (IL-8) in the Bronchoalveolar lavage fluid from patients with the adult respiratory distress syndrome (ARDS) and patients at risk for ARDS. Cytokine. 1992;4(6):592\u20137.","journal-title":"Cytokine"},{"key":"3849_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12950-018-0202-y","volume":"16","author":"S Spadaro","year":"2019","unstructured":"Spadaro S, Park M, Turrini C, Tunstall T, Thwaites R, Mauri T, et al. Biomarkers for acute respiratory distress syndrome and prospects for personalised medicine. J Inflamm Lond Engl. 2019;16:1.","journal-title":"J Inflamm Lond Engl"},{"key":"3849_CR44","doi-asserted-by":"crossref","unstructured":"Kurdowska A, Noble JM, Steinberg KP, Ruzinski JT, Hudson LD, Martin TR.\u00a0Anti-interleukin 8 autoantibody: interleukin 8 complexes in the acute respiratory distress\u00a0syndrome. Relationship between the complexes and clinical disease activity. Am J Respir Crit\u00a0Care Med. 2001;163(2):463-8.","DOI":"10.1164\/ajrccm.163.2.2005109"},{"issue":"1\u20132","key":"3849_CR45","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.cbi.2010.09.026","volume":"189","author":"JT Leverence","year":"2011","unstructured":"Leverence JT, Medhora M, Konduri GG, Sampath V. Lipopolysaccharide-induced cytokine expression in alveolar epithelial cells: role of PKC\u03b6-mediated p47phox phosphorylation. Chem Biol Interact. 2011;189(1\u20132):72\u201381.","journal-title":"Chem Biol Interact"},{"issue":"3","key":"3849_CR46","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.3390\/ijms21031148","volume":"21","author":"Z Nova","year":"2020","unstructured":"Nova Z, Skovierova H, Strnadel J, Halasova E, Calkovska A. Short-Term versus Long-Term culture of A549 cells for evaluating the effects of lipopolysaccharide on oxidative stress, surfactant proteins and Cathelicidin LL-37. Int J Mol Sci. 2020;21(3):1148.","journal-title":"Int J Mol Sci"},{"key":"3849_CR47","doi-asserted-by":"publisher","first-page":"78","DOI":"10.12688\/f1000research.2-78.v1","volume":"2","author":"T Yasutake","year":"2013","unstructured":"Yasutake T, Wada H, Higaki M, Nakamura M, Honda K, Watanabe M, et al. Anacardic acid, a histone acetyltransferase inhibitor, modulates LPS-induced IL-8 expression in a human alveolar epithelial cell line A549. F1000Res. 2013;2:78.","journal-title":"F1000Res"},{"issue":"11","key":"3849_CR48","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1038\/sj.bjc.6602227","volume":"91","author":"YM Zhu","year":"2004","unstructured":"Zhu YM, Webster SJ, Flower D, Woll PJ. Interleukin-8\/CXCL8 is a growth factor for human lung cancer cells. Br J Cancer. 2004;91(11):1970\u20136.","journal-title":"Br J Cancer"},{"issue":"4","key":"3849_CR49","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1007\/s00018-020-03656-y","volume":"78","author":"A Ciesielska","year":"2021","unstructured":"Ciesielska A, Matyjek M, Kwiatkowska K. TLR4 and CD14 trafficking and its influence on LPS-induced pro-inflammatory signaling. Cell Mol Life Sci. 2021;78(4):1233\u201361.","journal-title":"Cell Mol Life Sci"},{"key":"3849_CR50","doi-asserted-by":"publisher","first-page":"108635","DOI":"10.1016\/j.clim.2020.108635","volume":"222","author":"K Yuki","year":"2021","unstructured":"Yuki K, Hou L, Fujiogi M, Koutsogiannaki S, Soriano SG. Mechanistic consideration of the effect of perioperative volatile anesthetics on phagocytes. Clin Immunol Orlando Fla. 2021;222:108635.","journal-title":"Clin Immunol Orlando Fla"},{"key":"3849_CR51","doi-asserted-by":"publisher","first-page":"7507314","DOI":"10.1155\/2018\/7507314","volume":"2018","author":"X Lin","year":"2018","unstructured":"Lin X, Ju YN, Gao W, Li DM, Guo CC. Desflurane attenuates ventilator-induced lung injury in rats with acute respiratory distress syndrome. BioMed Res Int. 2018;2018:7507314.","journal-title":"BioMed Res Int"},{"key":"3849_CR52","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/1479-5876-11-87","volume":"11","author":"R Rodr\u00edguez-Gonz\u00e1lez","year":"2013","unstructured":"Rodr\u00edguez-Gonz\u00e1lez R, Baluja A, Veiras Del R\u00edo S, Rodr\u00edguez A, Rodr\u00edguez J, Taboada M, et al. Effects of Sevoflurane postconditioning on cell death, inflammation and TLR expression in human endothelial cells exposed to LPS. J Transl Med. 2013;11:87.","journal-title":"J Transl Med"},{"issue":"7","key":"3849_CR53","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1111\/j.1399-6576.2007.01363.x","volume":"51","author":"KA Boost","year":"2007","unstructured":"Boost KA, Flondor M, Hofstetter C, Platacis I, Stegewerth K, Hoegl S, et al. The beta-adrenoceptor antagonist propranolol counteracts anti-inflammatory effects of isoflurane in rat endotoxemia. Acta Anaesthesiol Scand. 2007;51(7):900\u20138.","journal-title":"Acta Anaesthesiol Scand"},{"issue":"2","key":"3849_CR54","doi-asserted-by":"publisher","first-page":"e0025021","DOI":"10.1128\/iai.00250-21","volume":"90","author":"K Freundt","year":"2022","unstructured":"Freundt K, Herzmann C, Biedziak D, Scheffz\u00fck C, Gaede KI, Stamme C. Surfactant protein A enhances the degradation of LPS-Induced TLR4 in primary alveolar macrophages involving Rab7, beta-arrestin2, and mTORC1. Infect Immun. 2022;90(2):e0025021.","journal-title":"Infect Immun"},{"issue":"4","key":"3849_CR55","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1165\/ajrcmb.19.4.3254","volume":"19","author":"AM LeVine","year":"1998","unstructured":"LeVine AM, Kurak KE, Bruno MD, Stark JM, Whitsett JA, Korfhagen TR. Surfactant Protein-A-deficient mice are susceptible to Pseudomonas aeruginosa infection. Am J Respir Cell Mol Biol. 1998;19(4):700\u20138.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"4","key":"3849_CR56","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.bpj.2017.06.059","volume":"113","author":"N Roldan","year":"2017","unstructured":"Roldan N, P\u00e9rez-Gil J, Morrow MR, Garc\u00eda-\u00c1lvarez B. Divide & conquer: surfactant protein SP-C and cholesterol modulate phase segregation in lung surfactant. Biophys J. 2017;113(4):847\u201359.","journal-title":"Biophys J"},{"issue":"8","key":"3849_CR57","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1016\/j.micinf.2006.04.009","volume":"8","author":"S Mulugeta","year":"2006","unstructured":"Mulugeta S, Beers MF. Surfactant protein C: its unique properties and emerging Immunomodulatory role in the lung. Microbes Infect. 2006;8(8):2317\u201323.","journal-title":"Microbes Infect"},{"issue":"4","key":"3849_CR58","doi-asserted-by":"publisher","first-page":"L776","DOI":"10.1152\/ajplung.2001.281.4.L776","volume":"281","author":"L Augusto","year":"2001","unstructured":"Augusto L, Le Blay K, Auger G, Blanot D, Chaby R. Interaction of bacterial lipopolysaccharide with mouse surfactant protein C inserted into lipid vesicles. Am J Physiol Lung Cell Mol Physiol. 2001;281(4):L776\u2013785.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"26","key":"3849_CR59","doi-asserted-by":"publisher","first-page":"23484","DOI":"10.1074\/jbc.M111925200","volume":"277","author":"LA Augusto","year":"2002","unstructured":"Augusto LA, Li J, Synguelakis M, Johansson J, Chaby R. Structural basis for interactions between lung surfactant protein C and bacterial lipopolysaccharide. J Biol Chem. 2002;277(26):23484\u201392.","journal-title":"J Biol Chem"},{"issue":"1","key":"3849_CR60","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1128\/IAI.71.1.61-67.2003","volume":"71","author":"LA Augusto","year":"2003","unstructured":"Augusto LA, Synguelakis M, Johansson J, Pedron T, Girard R, Chaby R. Interaction of pulmonary surfactant protein C with CD14 and lipopolysaccharide. Infect Immun. 2003;71(1):61\u20137.","journal-title":"Infect Immun"},{"key":"3849_CR61","doi-asserted-by":"crossref","unstructured":"Samary CS, Araujo MN, Santos CL, Cruz FF, Cavalcanti VM, Heil LB, et al. Effects ofinhaled anesthetics Sevoflurane and isoflurane on lung morphofunction and biologicalmarkers in experimental pulmonary and extrapulmonary acute respiratory distresssyndrome. Intensive Care Med Exp. 2015;3(1):A571.","DOI":"10.1186\/2197-425X-3-S1-A571"},{"key":"3849_CR62","doi-asserted-by":"crossref","unstructured":"Wright JR, Clements JA. Metabolism and turnover of lung surfactant. Am Rev RespirDis. 1987;136(2):426\u201344.","DOI":"10.1164\/ajrccm\/136.2.426"},{"key":"3849_CR63","doi-asserted-by":"crossref","unstructured":"Young PP, Mendelson CR. A CRE-like element plays an essential role in cAMP regulation of human SP-A2 gene in alveolar type II cells. Am J Physiol. 1996;271(2 Pt 1):L287\u2013299.","DOI":"10.1152\/ajplung.1996.271.2.L287"},{"key":"3849_CR64","doi-asserted-by":"crossref","unstructured":"McIntosh JC, Swyers AH, Fisher JH, Wright JR. Surfactant proteins A and D increase in response to intratracheal lipopolysaccharide. Am J Respir Cell Mol Biol. 1996;15(4):509\u201319.","DOI":"10.1165\/ajrcmb.15.4.8879185"},{"key":"3849_CR65","doi-asserted-by":"crossref","unstructured":"Chuang CY, Chen TL, Chen RM. Molecular mechanisms of lipopolysaccharide-caused induction of surfactant protein-A gene expression in human alveolar epithelial A549 cells. Toxicol Lett. 2009;191(2\u20133):132\u20139.","DOI":"10.1016\/j.toxlet.2009.08.015"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-025-03849-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-025-03849-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-025-03849-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T06:43:51Z","timestamp":1757486631000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-025-03849-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,9]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3849"],"URL":"https:\/\/doi.org\/10.1186\/s12890-025-03849-w","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,9]]},"assertion":[{"value":"15 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable: In this study only cell and bacterial culture experiments are reported.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable: In this study only cell and bacterial culture experiments are reported.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"PK reports personal fees and travel costs from Sedana Medical. All other authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"425"}}